We won't know that until the full results of the lupus trial and smoking cessation are announced, which will surely happen prior to needing to raise more capital. One is targeted for early licensing and the other is 'speed to market' approach, which I assume is meaning the same thing, so a lot hinges on a deal being struck. There is also the chance that the company will recover the money from the court case in the near future.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)